[2-(2-cyclohexylpropan-2-yloxy)-2-oxoethyl] 4-(3,3-dimethylpentan-2-yl)cyclohexa-1,5-diene-1-carboxylate
C25H40O4 — CID 123670794
Data last refreshed: (MolForge compound catalog, from PubChem)
About [2-(2-cyclohexylpropan-2-yloxy)-2-oxoethyl] 4-(3,3-dimethylpentan-2-yl)cyclohexa-1,5-diene-1-carboxylate
[2-(2-cyclohexylpropan-2-yloxy)-2-oxoethyl] 4-(3,3-dimethylpentan-2-yl)cyclohexa-1,5-diene-1-carboxylate (PubChem CID 123670794) has the molecular formula C25H40O4 and a molecular weight of 404.59 g/mol. Its IUPAC name is [2-(2-cyclohexylpropan-2-yloxy)-2-oxoethyl] 4-(3,3-dimethylpentan-2-yl)cyclohexa-1,5-diene-1-carboxylate.
Molecular Properties
| Compound Name | [2-(2-cyclohexylpropan-2-yloxy)-2-oxoethyl] 4-(3,3-dimethylpentan-2-yl)cyclohexa-1,5-diene-1-carboxylate |
|---|---|
| PubChem CID | 123670794 |
| Molecular Formula | C25H40O4 |
| Molecular Weight | 404.59 g/mol |
| Exact Mass | 404.29 |
| IUPAC Name | [2-(2-cyclohexylpropan-2-yloxy)-2-oxoethyl] 4-(3,3-dimethylpentan-2-yl)cyclohexa-1,5-diene-1-carboxylate |
| SMILES | CCC(C)(C)C(C)C1C=CC(C(=O)OCC(=O)OC(C)(C)C2CCCCC2)=CC1 |
| InChI | InChI=1S/C25H40O4/c1-7-24(3,4)18(2)19-13-15-20(16-14-19)23(27)28-17-22(26)29-25(5,6)21-11-9-8-10-12-21/h13,15-16,18-19,21H,7-12,14,17H2,1-6H3 |
| InChIKey | RAISXENMTVCQBC-UHFFFAOYSA-N |
| XLogP | 6.01 |
| TPSA | 52.60 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 404.59 |
| LogP ≤ 5 | 6.01 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 123670794 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.